대여금
1. The Defendant: (a) KRW 110,00,000 for the Plaintiff and KRW 12% per annum from April 1, 2016 to July 6, 2017; and (b) thereafter, the Plaintiff.
Based on the facts, the defendant, such as the status of the parties concerned, is a company with the main purpose of drug wholesale and retail business, and the plaintiff is a representative director of the defendant.
C is a substantial operator of the defendant.
On March 26, 2013, 180,000,000, 700,000 on April 16, 2013, 2013, the remittance date between the Plaintiff and the Defendant from the date of the transfer of money (on March 26, 2013, 200, 30,000 on May 13, 2013, 200, 40,000 on August 27, 2013, 205, 50,00 on December 30, 20, 200, 17, 200,007, 200,000, 200, 2000, 200,000, 30, 16, 30, 40, 206, 40, 206, 30, 2014
From November 15, 2013 to September 3, 2014, the Defendant remitted total of KRW 320,000,000 to the Plaintiff as indicated in the following table.
On November 15, 2013, the remittance date 10,000, 200, 2000, 30,000 on November 18, 2013, 203, 20, 30,000 on November 21, 2013, 20, 50,000 on the actual management status of the company, 50,000, 10,000 on May 11, 203, 203, 70,000, 60, 200, 70,000, 70,000, 70,000, 70,000, 320,000, 320,000, 300,000, 1510, 200, 15, 205, 201.
In addition, I will resign from the office of representative director and will not participate in any business other than the business (purchase and sale).
In the future, if there is another reason, or if there is another reason, it is wrong while the representative director is in office.